neostigmine methylsulfate has been researched along with Acute Confusional Senile Dementia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cholinergic hypothesis of Alzheimer's disease (AD) has spurred the development of numerous structural classes of compounds with different pharmacological profile aimed at increasing central cholinergic neurotransmission." | 1.33 | Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease. ( Narendra Sharath Chandra, JN; Ponnappa, KC; Rangappa, KS; Sadashiva, CT; Veerabasappa Gowda, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadashiva, CT | 1 |
| Narendra Sharath Chandra, JN | 1 |
| Ponnappa, KC | 1 |
| Veerabasappa Gowda, T | 1 |
| Rangappa, KS | 1 |
1 other study available for neostigmine methylsulfate and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Humans; Piperazines; Structure-A | 2006 |